Literature DB >> 2788471

Osteoclast formation from cloned pluripotent hemopoietic stem cells.

C E Hagenaars1, A A van der Kraan, E W Kawilarang-de Haas, J W Visser, P J Nijweide.   

Abstract

In the present report osteoclast formation from cloned pluripotent hemopoietic stem cells (PHSC) is described. Populations enriched in hemopoietic stem cells were cloned (1 cell/well) and cultured in the presence of different colony-stimulating factors, or combinations of these growth factors. In cultures containing interleukin-3 (Il-3) or pregnant mouse uterus extract (PMUE) alone, cloning efficiency was low. Cultures containing Il-3 and Il-1 or Il-3 and PMUE showed a somewhat higher cloning efficiency, whereas cultures containing Il-3, Il-1 and PMUE had the highest cloning efficiency. All colonies of cloned PHSC, tested for their osteoclast formation capability in cocultures with periosteum-free metatarsal bones of fetal mice, gave rise to osteoclast formation. Other hemopoietic cells could also be demonstrated. In control cultures in which the bones were kept without stem cells, no osteoclast formation was observed. In conclusion, we have demonstrated that the osteoclast is derived from the pluripotent hemopoietic stem cell. A combination of various growth factors is important for stem cell proliferation in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788471     DOI: 10.1016/0169-6009(89)90049-4

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  9 in total

Review 1.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

2.  Voltage-activated K+ conductances in freshly isolated embryonic chicken osteoclasts.

Authors:  J H Ravesloot; D L Ypey; T Vrijheid-Lammers; P J Nijweide
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  The role of macrophage stimulating factor M-CSF in bone resorption.

Authors:  H Fleisch; W Hofstetter; R Felix; M Cecchini; A Wetterwald
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

4.  Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.

Authors:  R J van't Hof; A C Tuinenburg-Bol Raap; P J Nijweide
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

5.  Osteoclast precursors circulate in avian blood.

Authors:  J I Alvarez; F P Ross; N A Athanasou; H C Blair; E M Greenfield; S L Teitelbaum
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

6.  Murine macrophage precursor cell lines are unable to differentiate into osteoclasts: a possible implication for osteoclast ontogeny.

Authors:  R De Grooth; R H Mieremet; E W Kawilarang-De Haas; P J Nijweide
Journal:  Int J Exp Pathol       Date:  1994-08       Impact factor: 1.925

7.  Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.

Authors:  T A Hentunen; S V Reddy; B F Boyce; R Devlin; H R Park; H Chung; K S Selander; M Dallas; N Kurihara; D L Galson; S R Goldring; B A Koop; J J Windle; G D Roodman
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

8.  NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone.

Authors:  M J Steinbeck; W H Appel; A J Verhoeven; M J Karnovsky
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

9.  Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor.

Authors:  H Kodama; A Yamasaki; M Nose; S Niida; Y Ohgame; M Abe; M Kumegawa; T Suda
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.